# FDA Inspection 1202011 - FDC Limited - February 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/fdc-limited/36cd0b59-9998-4a75-a57c-7e116edcc35e
Source feed: FDA_Inspections

> FDA Inspection 1202011 for FDC Limited on February 12, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202011
- Company Name: FDC Limited
- Inspection Date: 2023-02-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1062631 - 2018-08-16](https://www.keypedia.com/records/fda_inspections/fdc-limited/3205da5c-8721-40b4-b4b9-1cd628ab893f)
- [FDA Inspection 979497 - 2016-07-01](https://www.keypedia.com/records/fda_inspections/fdc-limited/10b446c1-be29-42d1-9603-f646e6a6aecd)
- [FDA Inspection 880907 - 2014-05-06](https://www.keypedia.com/records/fda_inspections/fdc-limited/7dcb3119-358e-4dbf-a964-30f093235f12)
- [FDA Inspection 776677 - 2012-02-21](https://www.keypedia.com/records/fda_inspections/fdc-limited/6907a179-b43d-4cd8-b235-4de8dd5656a5)

Company: https://www.keypedia.com/companies/fdc-limited/f1d7682a-697c-42a8-8b8f-7068fdbbee2a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c